Platelet inhibitors for TIAS

References

• Ramirez-Lassepas M. Transient ischemic attacks: the forewarning of stroke. Gertatrics 1980: 35(4): 73–83
   PubMedGoogle Scholar
• Barnett HJ. Pathogenesis of transient cerebral ischemic attacks in: Scheinberg P. ed. Cerebrovascular diseases: Princeton Conference on Cerebrovascular Diseases. 10th ed. New York: Raven Press. 1976: 1–21
   Google Scholar
• Ross R, Glomset JA. Harker LA. endothelium platelets, and smooth muscle in atherogenesis In Scheinberg. ed.2 pp 115–43
   Google Scholar
• Fields WS, Maalenikov V. Meyer JS, et al. Joint study of extracranial arterial occlusion V Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA 1970: 211 (Mar 23): 1993–2003
   PubMed Web of Science ®Google Scholar
• Whianant JP. Sandok BA. Sundt TM Jr. Carotid endarterectomy for unilateral carotid system transient cerebral ischemia Mayo Clin Proc 1983: 58(3): 171–5
   PubMed Web of Science ®Google Scholar
• Frank G. Comparison of anticoagulation and surgical treatments of TIA: a review and consolidation of recent natural history and treatment studies. Stroke 1971: 2 (Jul-Aug): 369–77
   PubMedGoogle Scholar
• Brust JC. Transient ischemic attacks: natural history and anticoagulation. Neurology 1977: 27(8): 701–7
   PubMed Web of Science ®Google Scholar
• Toole JF, Janeway R, Choi K. et al. Transient ischemic attacks due to atherosclerosis: a prospective study of 160 patients. Arch Neurol 1975: 32(1): 5–12
   PubMedGoogle Scholar
• Kuller LH. The transient ischemic attack: a critical review of anticoagulant and surgical therapy. Cutt Concepts Cerebrovasc Dis Stroke 1974: 9(6)23–6
   Google Scholar
• Sandok BA. Furlan AJ. Whisnant JP, et al. Guidelines for the management of transient ischemic attacks. Mayo Clin Proc 1978: 53(10): 665–74
   PubMed Web of Science ®Google Scholar
• Genton E, Gent M, Hirah J. et al. Platelet-inhibiting drugs in prevention of clinical thrombotic disease. N Eng J Med 1975: 293(23): 1174–8: 293(24): 1236–40: 293(25): 1296–300
   PubMed Web of Science ®Google Scholar
• Turpie AG. Hirsh J. Platelet suppressant therapy In: Joist HJ, Sherman LA, eds. Venous and arterial thrombosis: pathogenesis, diagnosis, prevention and therapy. New York: Grune & Stratton. 1979: 339–63
   Google Scholar
• Baenriger NL, Majerus PW. The mechanism of action of antiplatelet drugs, in: Joist. Sherman. eds.12 pp 327–8
   Google Scholar
• Rozenberg MC, Walker CM. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets Br J Haematol 1973: 24(Apr): 409–18
   PubMedGoogle Scholar
• Triplett DA. The platelet in normal hemostasts and thrombosis. In: Bang NU. Clover JL. Holden RW. et al. eds. Thrombosis and atherosclerosis Chicago: Year Book Medical Publishers. 1982: 303–21
   Google Scholar
• Triplett DA. The platelet: a review. In: Triplett DA. ed. Platelet function: laboratory evaluation and clinical application. Chicago: American Society of Clinical Pathology. 1978: 1–33
   Google Scholar
• Mielke CH Jr. Kanrshiro MM. Maher LA, et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969: 34(Aug): 204–15
   PubMedGoogle Scholar
• Ali M. McDonald JW. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. J Lab Clin Med 1977: 89(4): 868–75
   PubMed Web of Science ®Google Scholar
• Kinlough-Rathbone RL. The effects of some other drugs on platelet function. in: Hirsh J, Cade JF. Gallus AS. et al. eds. Platelets, drugs and thrombosis. New York: S Karger. 1975: 245–57
   Google Scholar
• Harrison MJ, Marshall J. Meadows JC. et al. Effect of aspirin in amaurosis fugax. Lancet 1971: 2(Oct 2): 743–4
   PubMed Web of Science ®Google Scholar
• Mundall J. gnintero P. Von Kaulla KN. et al. Transient monocular blindness and increased platelet aggregability treated with aspirin: a case report Neurology 1972: 22[Mar]: 280–5
   PubMedGoogle Scholar
• Evans G. Effects of drugs that suppress platelet surface Interaction on Incidence of amaurosis fugax and transient cerebral ischemia. Surg Forum 1972: 23: 239–41
   PubMedGoogle Scholar
• Dyken ML, Kolar OJ. Jonea FH. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapv. Stroke 1973: 4(Sep-Oct): 732–6
   PubMedGoogle Scholar
• Dyken ML. Transient ischemic attacks and stroke: aspirin trials. In: Bang, et al. eds.15 pp 393–404
   Google Scholar
• Acheson J, Danta G. Hutchinson EC. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J 1969: 1(Mar): 614–5
   PubMedGoogle Scholar
• Acheson J, Hutchinson EC. Controlled trial of clofibrate in cerebral vascular disease. Atherosclerosis 1972: 15(Mar-Apr): 177–83
   PubMedGoogle Scholar
• VA Cooperative Study Group. The treatment of cerebrovascular disease with clofibrate Stroke 1978: 4: 684–93
   Google Scholar
• The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke N Engl J Med 1978: 299(2): 53–9
   PubMed Web of Science ®Google Scholar
• Robertson JT. Critique to the Canadian “TIA” study. In: Price TR, Nelson E, eds Cerebrovascular diseases: Princeton Conference on Cerebrovascular Diseases. 11 th ed. New York: Raven Press. 1979: 251–3
   Google Scholar
• Roden S, Low-Beer T, Carmalt M. et al. Tran slent cerebral ischaemic attacks—management and prognosis. Postgrad Med J 1981: 57(667): 275–8
   PubMed Web of Science ®Google Scholar
• Candelise L. Landi G. Perrone P. et al. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke 1982: 13(2): 175–9
   PubMed Web of Science ®Google Scholar
• Fields WS. Lemak NA, Frankowskl RF, et al. Controlled trial of aspirin in cerebral ischemia. Stroke 1977: 8(3): 301–14
   PubMed Web of Science ®Google Scholar
• Fields WS, Lemak NA, Frankowski RF. et al. Controlled trial of aspirin in cerebral ischemia II Surgical group. Stroke 1978: 9(4): 309–19
   PubMed Web of Science ®Google Scholar
• Jestico J. Harrison MJ. Marshall J. Trial of aspirin during weaning patients with transient ischemic attacks from anticoagulants Br Med J 1978: 1(6121): 1 188
   PubMedGoogle Scholar
• Renther R, Dorndorf W. Aspirin in patients with cerebral ischemia and normal angiograms or nonsurgical lesions: the results of a double blind trial. In Breddin K. Dorndorf W. Loew D. et al. eds. Acetyl-salicylic acid in cerebral ischemia and coronary heart disease. Stuttgart: FK Schattauer Verlag. 1978: 97–106
   Google Scholar
• Guiraud-Chaumeil B. Rascol A. David J, et al. Prevention des recidives des accidents vasculaires cerebraux ischemiques par les anti-agregants plaquettaires: resultats d' un essat therapeutique controlé de 3 ans. Rev Neurol (Paris) 1982: 138(5): 367–85 (Fre)
   Google Scholar
• Bouaser MG. Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983: 14(1): 5–14
   PubMed Web of Science ®Google Scholar
• Garde A, Samuelsson K, Fahlgren E, et al. Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation. Stroke 1983: 14(5): 677–81
   PubMed Web of Science ®Google Scholar
• Sorensen PS, Pedersen H, Marquardsen J, et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danish cooperative study Stroke 1983: 14(1): 15–22
   Google Scholar
• Olsson JE, Brechter C, Backlund H, et al. Anticoagulant vs. antiplatelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 1980: 11 (1): 4–9
   PubMed Web of Science ®Google Scholar
• Buren A, Ygge J. Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. Stroke 1981: 12(2): 578–80
   PubMedGoogle Scholar
• Herskovits E, Famulart A, Tamaroff L. et al. Randomized trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischemic attacks. Lancet 1981: 1(8227): 966–8
   PubMed Web of Science ®Google Scholar
• Norrving B, Olsson JE, Nilsson B. Prophylactic treatment in patients with transient cerebral ischemia: anticoagulant vs. antiplatelet drugs. [Abstr) Thromb Haemost 1983: 50: 20
   Web of Science ®Google Scholar
• Müller R, Lehrach F. Hemorrheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline. Pharmatherapeutical 1980: 2(6): 372–9
   PubMedGoogle Scholar
• Koppenhagen K, Wenig HG, Muller K. The effect of pentoxifylline (Trental) on cerebral blood flow: a double-blind study Curr Med Res Opin 1977: 4(10): 681–7
   Web of Science ®Google Scholar
• Whisnant JP. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. (Letter) N Engl J Med 1978: 299(17): 953–4
   PubMed Web of Science ®Google Scholar
• Thompson JE. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. (Letter) N Engl J Med 1978: 299(17): 954
   Google Scholar
• Lilienfeld AM. Critique of “A randomized trial of aspirin and sulfinpyrazone in threatened stroke.” In: Price. Nelson, eds.29 pp 239–41
   Google Scholar
• Kurtzke JF. Critique of the Canadian “TIA” study In: Price. Nelson, eds.29 pp 243–50
   Google Scholar
• Sackett D. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. (Letter) N Engl J Med 1978: 299(17): 955
   Web of Science ®Google Scholar
• Dyken ML. Transient ischemic attacks and aspirin, stroke, and death: negative studies and type II error. Stroke 1983: 14(1): 2–4
   PubMed Web of Science ®Google Scholar
• Fisher CM. Transient ischemic attacks—an update. In: Scheinberg. ed,2 pp 50–3
   Google Scholar
• Carson SN, Demling RH. Esquivel CO. Aspirin failure in symptomatic atherosclerotic carotid artery disease. Surgery 1981: 90(6): 1084–92
   PubMed Web of Science ®Google Scholar
• The American-Canadian Cooperative Study Group. Persantine-aspirin trial in cerebral ischemia: progress report. Stroke 1983: 14(1): 99–103
   PubMed Web of Science ®Google Scholar